Free Trial

Crescent Capital BDC (NASDAQ:CCAP) Trading Down 3.5% - Here's What Happened

Crescent Capital BDC logo with Finance background

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report)'s share price dropped 3.5% during trading on Monday . The stock traded as low as $14.30 and last traded at $14.28. Approximately 177,865 shares were traded during mid-day trading, an increase of 27% from the average daily volume of 140,008 shares. The stock had previously closed at $14.80.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CCAP shares. Wells Fargo & Company lowered their price target on Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, May 16th. Wall Street Zen lowered Crescent Capital BDC from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Keefe, Bruyette & Woods downgraded Crescent Capital BDC from an "outperform" rating to a "market perform" rating and dropped their target price for the company from $18.50 to $17.00 in a report on Friday, May 16th. Finally, Raymond James Financial reduced their price target on shares of Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, Crescent Capital BDC has a consensus rating of "Hold" and an average price target of $17.60.

Get Our Latest Stock Report on Crescent Capital BDC

Crescent Capital BDC Trading Up 0.8%

The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.24. The firm's fifty day moving average is $15.41 and its 200 day moving average is $17.46.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($0.07). The business had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. Crescent Capital BDC had a net margin of 26.20% and a return on equity of 11.10%. On average, research analysts expect that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Monday, June 30th will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 11.63%. The ex-dividend date is Monday, June 30th. Crescent Capital BDC's dividend payout ratio (DPR) is currently 125.37%.

Institutional Investors Weigh In On Crescent Capital BDC

Several hedge funds have recently modified their holdings of CCAP. Montag A & Associates Inc. bought a new position in Crescent Capital BDC during the fourth quarter worth $35,000. C M Bidwell & Associates Ltd. acquired a new stake in Crescent Capital BDC in the 4th quarter worth $39,000. Aquatic Capital Management LLC bought a new position in shares of Crescent Capital BDC during the 4th quarter worth about $129,000. Generation Capital Management LLC bought a new position in shares of Crescent Capital BDC during the 4th quarter worth about $192,000. Finally, First Affirmative Financial Network acquired a new position in shares of Crescent Capital BDC during the first quarter valued at about $199,000. 49.46% of the stock is owned by institutional investors.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines